Yaron Naos

Yaron Naos appears in our data through filings on Protalix BioTherapeutics, Inc. shares, published by SEC (Form 4). In total, 2 filings cover trades dated from 15 August 2023 to 3 September 2025.

The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

On 4 September 2025 came the latest disclosure, a share grant in Protalix BioTherapeutics, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.